Blood transfusion reactions

Written by

in

 

Blood Transfusion Reactions: High-Yield Clinical Differentials

Blood transfusion reactions encompass a diverse spectrum of immunologic and non-immunologic adverse events occurring in response to the administration of allogeneic blood components. Clinical evaluation relies on precise timing of symptom onset, key pathophysiologic triggers, and distinguishing pulmonary versus systemic clinical presentation signs.

1. Acute Immunologic Reactions (Onset Within 24 Hours)

Acute reactions frequently present with overlapping initial features like fever or chills, making a clear structural understanding of underlying mechanisms crucial for emergency management:

Pathophysiology flowchart of Acute Hemolytic Transfusion Reaction demonstrating classical complement pathway activation on the red blood cell surface leading to intravascular hemolysis, free hemoglobin release, hemoglobinuria, and renal failure alongside mast cell histamine release causing hypotension and respiratory distress

The systemic cascade of an acute hemolytic reaction: pre-formed recipient antibodies trigger classical complement activation on donor red blood cells, causing catastrophic intravascular destruction.
Reaction Type Pathophysiology & Molecular Mechanism Clinical Findings & Management
Acute Hemolytic (AHTR) • Host pre-formed antibodies (typically IgM anti-A or anti-B) attack donor red blood cells due to ABO incompatibility errors.
• Drives type II hypersensitivity and classical complement pathway activation, resulting in severe intravascular hemolysis.		 • Triad of fever/chills, flank pain, and reddish-brown urine (hemoglobinuria).
• Can rapidly progress to DIC and acute renal failure.
• Positive Direct Antiglobulin Test (DAT/Coombs).
Febrile Non-Hemolytic • Most common reaction type.
• Caused by pre-formed recipient antibodies reacting against donor white blood cells, or accumulated biologic response modifiers (cytokines like IL-1, IL-6, TNF-alpha) synthesized by donor leukocytes during storage.		 • Fever, chills, and mild rigors within 1 to 6 hours of starting transfusion.
• Management: Acetaminophen.
• Prevention: Leukoreduction of blood components before storage.
Allergic & Anaphylactic • Type I hypersensitivity reaction against soluble donor plasma proteins.
• Severe anaphylaxis occurs classically in IgA-deficient recipients who possess pre-formed anti-IgA antibodies reacting to infused donor IgA.		 • Mild: Localized urticaria and pruritus.
• Severe: Dyspnea, wheezing, stridor, and profound hypotension.
• Treatment: Epinephrine for anaphylaxis; antihistamines for mild hives.
Transfusion-Related Acute Lung Injury (TRALI) • Two-hit hypothesis: Recipient neutrophils sequester in pulmonary capillaries (hit 1), followed by activation by donor anti-HLA or anti-neutrophil antibodies (hit 2).
• Leads to endothelial damage, capillary leak, and non-cardiogenic pulmonary edema.		 • Acute respiratory distress, hypoxemia, and bilateral pulmonary infiltrates on chest X-ray within 6 hours.
• Characterized by fever and hypotension.
• Management: Supportive care; avoid aggressive diuretics.

2. Delayed and Non-Immunologic Reactions

These conditions feature distinct physiological pathways, presenting either as structural volume overloads or delayed cellular clearance:

  • Transfusion-Associated Circulatory Overload (TACO):
    A non-immunologic reaction caused by the rapid infusion of volume that exceeds the compensatory capacity of the recipient’s cardiovascular system. It is most common in patients with pre-existing chronic kidney disease or compromised left ventricular function.

    • Clinical Presentation: Dyspnea, tachypnea, cyanosis, and hypertension. Physical exam shows jugular venous distension (JVD), bilateral pulmonary crackles, and peripheral edema. Unlike TRALI, TACO presents with **elevated BNP** and responds rapidly to intravenous loop diuretics (furosemide).

  • Delayed Hemolytic Transfusion Reaction (DHTR):
    An amnestic immune response occurring 3 to 10 days post-transfusion. It is triggered when a patient is re-exposed to foreign minor red blood cell antigens (such as Rh, Kell, Kidd, or Duffy groups) to which they were previously sensitized.

    • Clinical Presentation: Typically mild and gradual. Presents as an unexplained, steady drop in hemoglobin, low-grade fever, and mild jaundice due to extravascular hemolysis by splenic macrophages.

Immediate Emergency Protocol: If a transfusion reaction is suspected, the absolute first step is to immediately stop the transfusion, maintain venous access with normal saline, and cross-check all patient identification labels with the blood bank unit.